» Articles » PMID: 28436239

Clinical Applications of Quantitative Proteomics Using Targeted and Untargeted Data-independent Acquisition Techniques

Overview
Publisher Informa Healthcare
Date 2017 Apr 25
PMID 28436239
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

While selected/multiple-reaction monitoring (SRM or MRM) is considered the gold standard for quantitative protein measurement, emerging data-independent acquisition (DIA) using high-resolution scans have opened a new dimension of high-throughput, comprehensive quantitative proteomics. These newer methodologies are particularly well suited for discovery of biomarker candidates from human disease samples, and for investigating and understanding human disease pathways. Areas covered: This article reviews the current state of targeted and untargeted DIA mass spectrometry-based proteomic workflows, including SRM, parallel-reaction monitoring (PRM) and untargeted DIA (e.g., SWATH). Corresponding bioinformatics strategies, as well as application in biological and clinical studies are presented. Expert commentary: Nascent application of highly-multiplexed untargeted DIA, such as SWATH, for accurate protein quantification from clinically relevant and disease-related samples shows great potential to comprehensively investigate biomarker candidates and understand disease.

Citing Articles

Proteomic Profiling Towards a Better Understanding of Genetic Based Muscular Diseases: The Current Picture and a Look to the Future.

Pauper M, Hentschel A, Tiburcy M, Beltran S, Ruck T, Schara-Schmidt U Biomolecules. 2025; 15(1).

PMID: 39858524 PMC: 11763865. DOI: 10.3390/biom15010130.


Mass Spectrometry-Based Proteomics for Classification and Treatment Optimisation of Triple Negative Breast Cancer.

Metwali E, Pennington S J Pers Med. 2024; 14(9).

PMID: 39338198 PMC: 11432759. DOI: 10.3390/jpm14090944.


Comprehensive Overview of Bottom-Up Proteomics Using Mass Spectrometry.

Jiang Y, Rex D, Schuster D, Neely B, Rosano G, Volkmar N ACS Meas Sci Au. 2024; 4(4):338-417.

PMID: 39193565 PMC: 11348894. DOI: 10.1021/acsmeasuresciau.3c00068.


Amniotic fluid proteomic analysis identifies IL1RL1, APOE, and NECTIN4 as new biomarkers for preterm birth.

Li M, Liu M, Chen P, Duan S, Li Y, Ma Q BMC Pregnancy Childbirth. 2024; 24(1):530.

PMID: 39134987 PMC: 11321064. DOI: 10.1186/s12884-024-06734-2.


Enabling population protein dynamics through Bayesian modeling.

Lehmann S, Vialaret J, Gabelle A, Bauchet L, Villemin J, Hirtz C Bioinformatics. 2024; 40(8).

PMID: 39078204 PMC: 11335370. DOI: 10.1093/bioinformatics/btae484.


References
1.
Gallien S, Bourmaud A, Kim S, Domon B . Technical considerations for large-scale parallel reaction monitoring analysis. J Proteomics. 2013; 100:147-59. DOI: 10.1016/j.jprot.2013.10.029. View

2.
Liu Y, Chen J, Sethi A, Li Q, Chen L, Collins B . Glycoproteomic analysis of prostate cancer tissues by SWATH mass spectrometry discovers N-acylethanolamine acid amidase and protein tyrosine kinase 7 as signatures for tumor aggressiveness. Mol Cell Proteomics. 2014; 13(7):1753-68. PMC: 4083113. DOI: 10.1074/mcp.M114.038273. View

3.
Whiteaker J, Halusa G, Hoofnagle A, Sharma V, MacLean B, Yan P . Using the CPTAC Assay Portal to Identify and Implement Highly Characterized Targeted Proteomics Assays. Methods Mol Biol. 2016; 1410:223-36. PMC: 5017244. DOI: 10.1007/978-1-4939-3524-6_13. View

4.
Bereman M, Beri J, Sharma V, Nathe C, Eckels J, MacLean B . An Automated Pipeline to Monitor System Performance in Liquid Chromatography-Tandem Mass Spectrometry Proteomic Experiments. J Proteome Res. 2016; 15(12):4763-4769. PMC: 5406750. DOI: 10.1021/acs.jproteome.6b00744. View

5.
Teo G, Kim S, Tsou C, Collins B, Gingras A, Nesvizhskii A . mapDIA: Preprocessing and statistical analysis of quantitative proteomics data from data independent acquisition mass spectrometry. J Proteomics. 2015; 129:108-120. PMC: 4630088. DOI: 10.1016/j.jprot.2015.09.013. View